Sam Ishmael Hooshmand

Sam Hooshmand practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Sam Hooshmand's NPI, 1417310665, was assigned on April 4, 2016. Sam Hooshmand holds Wisconsin license 69225.

Sam Hooshmand's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Sam Hooshmand's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Sam Hooshmand is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Sam Hooshmand to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sam Hooshmand practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Sam Hooshmand's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Sam Hooshmand is licensed in Wisconsin.

CMS data shows 210 Medicare services from Sam Hooshmand across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $12,782 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Sam Hooshmand in 2024. The largest group is 65 to 74, with 43 patients. 54% of them have high blood pressure, and 50% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sam Hooshmand's median patient age at 51, with 68% women.

In 2024, Sam Hooshmand wrote 1,255 Medicare Part D claims for 128 patients. 89% of them were for generic drugs. CMS names the drug for 921 of them, across 23 drugs with 11 or more claims each, at $331,000 in total drug cost. In 2023, CMS named 327 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Sam Hooshmand for performance year 2024, reported as part of a group. Sam Hooshmand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sam Hooshmand as offering telehealth.

Dmand AI links 6 papers to Sam Hooshmand, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Autoantibodies. Sam Hooshmand's most frequent co-authors are Ahmed Zayed Obeidat, MD, PhD, Allison Noel Block, DO and Ryan Tomas Brennan, DO.

CMS Open Payments shows 236 general payments to Sam Hooshmand from 11 drug and device companies from 2020 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. TG Therapeutics, Inc. paid the most, $89,478.